Design, synthesis and cytotoxic activities of novel hybrid compounds between dihydrobenzofuran and imidazole.

A series of novel hybrid compounds between dihydrobenzofuran and imidazole has been prepared and evaluated in vitro against a panel of human tumor cell lines. The results suggest that substitution of the imidazolyl-1-position with an electron-donating dihydrobenzofuran, and the imidazolyl-3-position with a naphthylacyl or electron-rich phenacyl group, were vital for modulating cytotoxic activity.

[1]  S. H. Alves,et al.  Imidazolium ionic liquids containing selenium: synthesis and antimicrobial activity. , 2011, Organic & biomolecular chemistry.

[2]  S. Katiyar,et al.  Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agents. , 2010, European journal of medicinal chemistry.

[3]  Hongbin Zhang,et al.  Synthesis and antitumor activity of 1-mesityl-3-(2-naphthoylmethano)-1H-imidazolium bromide. , 2010, Bioorganic & medicinal chemistry letters.

[4]  K. Harada,et al.  A new approach to benzofuran synthesis: Lewis acid mediated cycloaddition of benzoquinones with stilbene oxides , 2010 .

[5]  A. Ajay,et al.  Application of Huisgen (3+2) cycloaddition reaction: synthesis of 1-(2,3-dihydrobenzofuran-2-yl-methyl [1,2,3]-triazoles and their antitubercular evaluations. , 2010, European journal of medicinal chemistry.

[6]  C. Grütter,et al.  Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc. , 2009, Journal of medicinal chemistry.

[7]  P. Pandey,et al.  Reactions of 2-hydroxyaryl-α,β-unsaturated ketones with dimethylsulfonium carbonylmethylides : a new and facile diastereoselective synthesis of 2,3-disubstituted dihydrobenzofurans , 2009 .

[8]  S. Manna,et al.  A dihydrobenzofuran lignan induces cell death by modulating mitochondrial pathway and G2/M cell cycle arrest. , 2009, Journal of medicinal chemistry.

[9]  Xianghui Zeng,et al.  Synthesis and cytotoxic activities of novel phenacylimidazolium bromides. , 2009, Bioorganic & medicinal chemistry letters.

[10]  T. Nagamatsu,et al.  Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin-cholestane hybrid compounds. , 2008, Bioorganic & medicinal chemistry.

[11]  V. Andrisano,et al.  Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity. , 2008, Journal of medicinal chemistry.

[12]  Giuseppe Musumarra,et al.  Design and synthesis of trans 2-(furan-2-yl)vinyl heteroaromatic iodides with antitumour activity. , 2008, Bioorganic & medicinal chemistry.

[13]  A. Yadav,et al.  An elegant and unprecedented approach to 2-methylbenzofurans , 2007 .

[14]  L. Gundersen,et al.  Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs. , 2007, Bioorganic & medicinal chemistry.

[15]  Jean Martínez,et al.  Efficient synthetic approach to heterocycles possessing the 3,3-disubstituted-2,3-dihydrobenzofuran skeleton via diverse palladium-catalyzed tandem reactions , 2007 .

[16]  D. Enders,et al.  Asymmetric Organocatalytic Synthesis of cis-Substituted Dihydrobenzofuranols via Intramolecular Aldol Reactions. , 2006 .

[17]  Hong-hui Lin,et al.  Monometallic complexes of 1,4,7,10-tetraazacyclododecane containing an imidazolium side: synthesis, characterization, and their interaction with plasmid DNA. , 2006, Bioorganic & medicinal chemistry.

[18]  R. Gambari,et al.  Design, Synthesis, and Biological Evaluation of Hybrid Molecules Containing α-Methylene-γ-Butyrolactones and α-Bromoacryloyl Moieties , 2005 .

[19]  K. Kaliappan,et al.  Design and synthesis of novel sugar-oxasteroid-quinone hybrids. , 2005, Organic & biomolecular chemistry.

[20]  L. Pieters,et al.  Antileishmanial activity, cytotoxicity and QSAR analysis of synthetic dihydrobenzofuran lignans and related benzofurans. , 2005, Bioorganic & medicinal chemistry.

[21]  J. Halperin,et al.  Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation. , 2004, Journal of medicinal chemistry.

[22]  A. Xu,et al.  Synthesis, acute toxicities, and antitumor effects of novel 9-substituted beta-carboline derivatives. , 2004, Bioorganic & medicinal chemistry.

[23]  Richard Morphy,et al.  From magic bullets to designed multiple ligands. , 2004, Drug discovery today.

[24]  G. Musumarra,et al.  Design, synthesis and in vitro antitumor activity of new trans 2-[2-(heteroaryl)vinyl]-1,3-dimethylimidazolium iodides. , 2004, Bioorganic & medicinal chemistry.

[25]  K. He,et al.  Imidazole alkaloids from Lepidium meyenii. , 2003, Journal of natural products.

[26]  Alberto Martínez,et al.  Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. , 2002, Journal of medicinal chemistry.

[27]  D. Ryu,et al.  Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues. , 2001, Journal of medicinal chemistry.

[28]  M. Segawa,et al.  Design, synthesis and antimuscarinic activity of some imidazolium derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[29]  Keisuke Suzuki,et al.  Total Synthesis of the Furaquinocins , 1998 .

[30]  Hans Achenbach,et al.  Lignans fromKrameria ixina , 1991 .

[31]  S. J. Dominianni,et al.  Oral hypoglycemic agents. Discovery and structure-activity relationships of phenacylimidazolium halides. , 1989, Journal of medicinal chemistry.

[32]  S. Wong,et al.  Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. , 1987, Journal of medicinal chemistry.